Testimony to Congress

The testimony of NIDA Director, Nora D. Volkow, M.D., and other senior staff before congress.

Federal Efforts to Combat the Opioid Crisis: A Status Update on CARA and Other Initiatives (October 25, 2017)
The Federal Response to the Opioid Crisis (October 05, 2017)
Research on the Use and Misuse of Fentanyl and Other Synthetic Opioids (June 30, 2017)
Fiscal Year 2017 Budget Request (July 29, 2016)
Researching the Potential Medical Benefits and Risks of Marijuana (July 13, 2016)
What Science tells us About Opioid Abuse and Addiction (January 27, 2016)
Fiscal Year 2016 Budget Request (July 27, 2015)
The Biology and Potential Therapeutic Effects of Cannabidiol (June 24, 2015)
What is the Federal Government Doing to Combat the Opioid Abuse Epidemic? (May 01, 2015)
Fiscal Year 2015 Budget Request (August 12, 2014)
Mixed Signals: The Administration’s Policy on Marijuana, Part Four -- Scientific Focus on the Adverse Health Effects of Marijuana Use (June 20, 2014)
America’s Addiction to Opioids: Heroin and Prescription Drug Abuse (May 14, 2014)
Prescription Opioid and Heroin Abuse (April 29, 2014)
Harnessing the Power of Science to Inform Substance Abuse and Addiction Policy and Practice (April 02, 2014)
Dangerous Synthetic Drugs (September 25, 2013)

Menu